Well-differentiated Non-functional NET of Pancreatic Origin

Explore clinical trials studying Well-differentiated Non-functional NET of Pancreatic Origin. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Well-differentiated Non-functional NET of Pancreatic Origin trial results

Completed

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

NCT02955069

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: City of Hope National Medical Center Duarte, California, United States

Rocky Mountain Cancer Centers SC-2 Denver, Colorado, United States

H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Mayo Clinic - Rochester Rochester, Minnesota, United States

View all 35 locations

View Trial Details

Well-differentiated Non-functional NET of Pancreatic Origin

Well-differentiated Non-functional NET of Pancreatic Origin trial results

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Related conditions